By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Ohio State and Microsoft build a hospital that senses itself
    By
    msadmin
    November 11, 2026
    Charta raises $55M to settle claims before doctors bill
    By
    msadmin
    November 11, 2026
    Oura spends $625M to put doctors behind its ring
    By
    msadmin
    November 11, 2026
    Google puts an agent layer under every hospital workflow
    By
    msadmin
    November 11, 2026
    XtalPi hands Pierre Fabre a molecule factory for stubborn cancer targets
    By
    msadmin
    November 10, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

10x Genomics hands single cell analysis to a Claude agent

Sentira Single Cell lets researchers ask questions in plain language and returns a reproducible notebook instead of a black box.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: November 4, 2026
Share
2 Min Read
SHARE

Single cell datasets grow faster than most labs can quiz them. On November 2, 10x Genomics launched Sentira Single Cell, a cloud tool that lets researchers put biological questions to their Chromium data in ordinary language and assigns the planning to an AI agent.

Contents
Why the notebook matters more than the chatA platform play, not a one-off feature

The agent is Anthropic’s Claude. Given a hypothesis, it maps out an approach, writes out a plan, lets the researcher review and adjust it, carries out the steps and delivers findings. Everything lands in an editable notebook that preserves the code behind every figure.

Why the notebook matters more than the chat

Agentic tools in biology invite a fair question about verification. 10x’s answer: the reasoning trail ships with the output. Researchers can ask follow-ups, request changes, and inspect how a figure was reached. That keeps a human in the loop without making them write the pipeline by hand.

Hosted on 10x Cloud, the service supplies compute for Chromium datasets of any size and runs several analyses in parallel, so labs provision nothing themselves. Henry Long, scientific director at Dana-Farber Cancer Institute, noted that the questions themselves are old news; asking them in natural language is what changes how fast answers arrive.

A platform play, not a one-off feature

Sentira arrived as a computational platform in late September, plus a spatial analysis app in Early Access. A natural-language layer turns that infrastructure into something closer to a research collaborator. The company cites a standing bottleneck: labs produce rich, high-dimensional measurements, yet turning them into tested ideas remains slow.

Accessibility cuts both ways. Cheaper analysis widens who can query single cell data, and it raises the rigor bar, since a plausible figure nobody rebuilt by hand is easy to accept and hard to defend. Introductory credits are available now, then consumption pricing.

TAGGED:Agentic AIAIAnthropic Claudebiotech toolsGenomicslaboratory automationsingle cell
SOURCES:BioSpaceGEN
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Theranica finds a month of headache logs beats aura signals

By
msadmin
September 25, 2026
News & AlertsSpotlight

Pharma AI Alliance Expands: Owkin and AstraZeneca Deploy New Drug Discovery Models

By
msadmin
May 14, 2026
News & Alerts

Study finds almost no FDA-cleared AI devices tested on outcomes

By
msadmin
August 22, 2026
News & Alerts

FOCUS AI model automates the full OCT retina diagnostic path

By
msadmin
August 23, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal